Investors

Welcome to our Investor page. Here you will find information on the latest ASX announcements, investor presentations and other shareholder information on Race Oncology.

Welcome to our Investor page. Here you will find information on the latest ASX announcements, investor presentations and other shareholder information on Race Oncology.

INVESTOR HUB

Share Price

Latest News

ASX Release
Race Develops Improved IV Formulation of Zantrene

on by Daniel Tillett – 0 comments

To discuss or comment on this announcement please visit our Investor Hub.

ASX Release
Race Initiates FTO & ALKBH5 Drug Discovery Program

on by Daniel Tillett – 0 comments

To discuss or comment on this announcement please visit our Investor Hub.

ASX Release
Race Oncology 2022 Annual Report

on by Daniel Tillett – 0 comments

Race Oncology June 2022 Quarterly Investor Briefing
Featured
Race Oncology June 2022 Quarterly Investor Briefing

on by Daniel Tillett – 0 comments

Race Oncology CEO Phillip Lynch and CSO Dr Daniel Tillett present Race’s June 2022 Quarterly I…

ASX Release
June 2022 Quarterly Activity Report

on by Daniel Tillett – 0 comments